GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Gross-Profit-to-Asset %

Rua Bioscience (NZSE:RUA) Gross-Profit-to-Asset % : 5.36% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Rua Bioscience's annualized Gross Profit for the quarter that ended in Dec. 2024 was NZ$0.41 Mil. Rua Bioscience's average Total Assets over the quarter that ended in Dec. 2024 was NZ$7.73 Mil. Therefore, Rua Bioscience's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 5.36%.


Rua Bioscience Gross-Profit-to-Asset % Historical Data

The historical data trend for Rua Bioscience's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Gross-Profit-to-Asset % Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Gross-Profit-to-Asset %
- -0.31 0.07 -0.82

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only -0.38 0.62 -0.04 -2.59 5.36

Competitive Comparison of Rua Bioscience's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rua Bioscience's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's Gross-Profit-to-Asset % falls into.


;
;

Rua Bioscience Gross-Profit-to-Asset % Calculation

Rua Bioscience's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=-0.118/( (20.951+7.74)/ 2 )
=-0.118/14.3455
=-0.82 %

Rua Bioscience's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0.414/( (7.74+7.722)/ 2 )
=0.414/7.731
=5.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Rua Bioscience Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rua Bioscience Business Description

Traded in Other Exchanges
N/A
Address
1 Commerce Place, Awapuni, Gisborne, NZL, 4071
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany and New Zealand.

Rua Bioscience Headlines

No Headlines